Lewis-Sumner syndrome in hepatitis C virus infection: A possible pathogenetic association with therapeutic problems

Muscle and Nerve

Volumn 34, Issue 1, 2006, Pages 116-121

  Caporale, Christina M ^a   Capasso, Margherita ^a   Ragno, Michele ^b   Di Muzio, Antonio ^a   Uncini, Antonino ^a  

^a Clinica Neurologica   (Italy)

^b C and G Mazzoni Hospital   (Italy)

Author keywords

Hepatitis C virus (HCV); Interferon alpha; Intravenous immunoglobulins; Lewis Sumner syndrome; Methylprednisolone

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RIBAVIRIN; STEROID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE EXACERBATION; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNE DYSREGULATION; LEWIS SUMNER SYNDROME; MALE; MOTOR NERVE CONDUCTION; MUSCLE WEAKNESS; NERVE BIOPSY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RELAPSE; REMISSION; SURAL NERVE; TREATMENT RESPONSE;

ADULT; DEMYELINATING DISEASES; DISABILITY EVALUATION; ELBOW; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MUSCLE WEAKNESS; NEURAL CONDUCTION; SENSATION DISORDERS; STEROIDS; TIME FACTORS; WRIST;

EID: 33745686646     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1016/j.foodqual.2005.07.011     Document Type: Article

References (37)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.
2. American Association of Electrodiagnostic Medicine. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 1999;22:225-229.
3. Apartis E, Lger LM, Musset L, Gigenheim M, Cacoub P, Lyon-Caen O, et al. Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry 1996;60:661-666.
4. Authier FJ, Pawlotsky JM, Viard, L Guillvin JP, Degos JD, Gherardi RK. High incidence of hepatitis C virus infection in patients with cryoglobulinemic neuropathy. Ann Neurol 1993;34:749-750.
5. Boonyapisit K, Katirji B. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon-alpha: a case report and literature review. Muscle Nerve 2002;25:909-913.
6. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine 2000;79:47-56.
7. Corcia P, Barbereau D, Guennoc AM, de Toffol B, Bacq Y. Improvement of a CIDP associated with hepatitis C virus infection using antiviral therapy. Neurology 2004;63:179-180.
8. Cornblath DR, Sumner AJ. Conduction block in neuropathies with necrotizing vasculitic. Muscle Nerve 1991;14:185-186.
9. Cudillo L, Cantonetti M, Venditti A, Lentini R, Rossigni PM, Caramia M, et al. Peripheral neuropathy during treatment with alpha-2 interferon. Haematologica 1990;75:485-486.
10. Davis GL, Balart LA, Schiff ER, Linsay K, Bodenheimer HC Jr, Perillo RP, et al. Treatment of chronic hepatitis C with recomibinant interferon alpha: a multicenter randomised, controlled trial. N Engl J Med 1989;321:1501-1506.
11. Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590-596.
12. Dyck PJ, Giannini C, Lais A. Pathologic alteration of nerves. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia. WB Saunders; 1993. p 514-595.
13. Gastineau DA, Habermann TM, Hermann RC. Severe neuropathy associated with low-dose recombinant interferon-alpha. Am J Med 1989;87:116.
14. Ghini M. Treatment of cryoglohulinemic neuropathy with alpha interferon. Neurology 1996;47:588-589.
15. Gibbels E, Behse F, Kentenich M, Haupt WF. Chronic multifocal neuropathy with persistent conduction block (Lewis-Sumner syndrome): a clinico-morphologic study of two further cases with review of the literature. Clin Neuropathol 1993;12:343-352.
16. Gledhill RF, Inshasi J. Conduction block in vasculitic neuropathy. Neurology 1992;42:699.
17. Gorson KC, Allam G, Simovic D, Ropper AH. Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy. Neurology 1997;48:777-780.
18. Fattovich G, Giustina G, Favarato S, Ruoal A. A survey of adverse events in 11,241 patients with chronic hepatitis treated with alfa interferon. J Hepatol 1996;24:38-47.
19. Harada H, Ohkoshi N, Fujita Y, Tamaoka A, Shoji S. Clinical improvement following interferon-alpha alone as an initial treatment in CIDP. Muscle Nerve 2000;23:295-296.
20. Jamieson PW, Giuliani MJ, Martinez AJ. Necrotizing angiopathy presenting with multifocal conduction blocks. Neurology 1991;41:442-444.
21. Khella SL, Frost S, Hermann GA, Leventhal L, Whyatt S, Sajid BA, et al. Hepatitis C infection cryoglobulinaemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review. Neurology 1995;45:407-411.
22. Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32:958-964.
23. Lewis RA. Multifocal motor neuropathy and Lewis-Sumner syndrome: two distinct entities. Muscle Nerve 1999;22:1738.
24. Lidove O, Cacoub P, Maisonobe T, Servan J, Thibault V, Piette JC, et al. Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia. Ann Rheum Dis 2001;60:290-292.
25. Marzo E, Tintore M, Fabregues O, Montalban X, Codina A. Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-α. J Neurol Neurosurg Psychiatry 1998;65:604.
26. McMurray RW. Hepatitis C-associated autoimmune disorders virus infection. Rheum Dis Clin N Am 1998;24:353-374.
27. Meriggioli MN, Rowin J. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-α. Muscle Nerve 2000;23:433-435.
28. Nemni R, Sanvito L, Quattrini A, Santuceio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry 2003;74:1267-1271.
29. Nukada H, Pollock M, Haas LF. Is ischemia implicated in chronic multifocal demyelinating neuropathy? Neurology 1989;39:106-110.
30. Oh SJ, Claussen GC, Dae SK. Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 1997;2:362-369.
31. Pavesi G, Cattaneo L, Marbini A, Gemignani F, Mancia D. Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy. J Neurol 2002;249:777-779.
32. Ropert A, Metral S. Conduction block in neuropathies with necrotizing vasculitic. Muscle Nerve 1990;13:102-105.
33. Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, Jackson CE, et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 1999;22:560-566.
34. Uncini A, England JD, Rhee EK, Duckett SW, Sumner AJ. Tellurium-induced demyelination: an electrophysiological and morphological study. Muscle Nerve 1988;11:871-879.
35. Van den Berg-Vos RM, Van den Berg LH, Franssen H, Vermeulen M, Witkamp TD, Jansen GH, et al. Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity? Neurology 2000;54:26-32.
36. Verschueren A, Azulay JP, Attarian S, Boucraut J, Pellissier JF, Pouget J. Lewis-Sumner and multifocal motor neuropathy. Muscle Nerve 2005;31:88-94.
37. Viala K, Renie L, Maisonohe T, Behin A, Neil J, Leger JM, Bouche P. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 2004;127:2010-2017.